Circulating Tumor DNA as a Prognostic Determinant in Small Cell Lung Cancer Patients Receiving Atezolizumab.
Herbreteau G, Langlais A, Greillier L, Audigier-Valette C, Uwer L, Hureaux J, Moro-Sibilot D, Guisier F, Carmier D, Madelaine J, Otto J, Souquet PJ, Gounant V, Merle P, Molinier O, Renault A, Rabeau A, Morin F, Denis MG, Pujol JL.
Herbreteau G, et al. Among authors: carmier d.
J Clin Med. 2020 Nov 27;9(12):3861. doi: 10.3390/jcm9123861.
J Clin Med. 2020.
PMID: 33261056
Free PMC article.